Latest news

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=5502&f=G&l=50&d=PTXT&p=111&S1=20220531&OS=20220531&RS=20220531

  On Wednesday, 807 companies reached new 52-week lows.

Immatics N.V. (NASDAQ: IMTX) announced the initiation of a Phase 1 clinical trial of its drug candidate IMA401 for patients with recurrent and/or refractory solid tumors.

SVB Leerink analyst Jonathan Chang maintains Immatics (NASDAQ:IMTX) with a Outperform and lowers the price target from $32 to $25.

  On Wednesday, 90 companies set new 52-week lows.

  During Tuesday's session, 454 stocks hit new 52-week lows.

    On Friday, 368 stocks hit new 52-week lows.

    During Tuesday's trading, 505 companies set new 52-week lows.

    On Friday, 313 companies hit new 52-week lows.

View Patent here